Also the investigation of a BBS-2, a more potent selective NOS2 inhibitor, was not capable of reversing the sepsis induced vasodilatation [207], which may indicate that NOS2 may not or only partially be involved in the vasodilatation during sepsis and inflammation. The gene discussed is NOS2; the disease is Sepsis.